Valeant Pharma (VRX) Reverses Higher
- S&P little changed as energy weighs but financials edge up
- Nestle Said Examining Takeover of Mead Johnson (MJN) - Source
- Fed's Yellen says 'makes sense' to gradually raise interest rates
- UPDATE: Fed Beige Book: Wages gain modestly in most areas amid tight job market
- Mallinckrodt (MNK) Announces FTC Settlement
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Valeant Pharma (NYSE: VRX) reverses higher after this morning's negative note. Shares are up 2.1%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Yellen Says Fed Close to Dual Goals, Can't Give Timing of Next Hike
- Bridgepoint Education (BPI) Gains on Heavy Relative Volume
- Netflix (NFLX) January 132 straddle priced for movement of 9.4% into Q4
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!